Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Bausch Health Companies Inc BHC


Primary Symbol: T.BHC

Healthcare
Bausch Health Companies Inc. is a global diversified pharmaceutical company. The Company develops, manufactures and markets, primarily in the therapeutic areas of gastroenterology (GI), hepatology, neurology and dermatology, and others, through Bausch + Lomb Corporation. Its Salix segment consists of sales in the United States of GI products. Its International segment consists of sales, with... see more

Recent & Breaking News (TSX:BHC)

Bausch + Lomb Introduces enVista® Toric MX60ET Intraocular Lens With StableFlex(TM) Technology

Canada NewsWire December 11, 2019

Bausch + Lomb And TerraCycle Announce Donation Of New Custom Training Modules Incorporating Used Contact Lens Materials To Guide Dog Foundation

Canada NewsWire November 13, 2019

Bausch Health Companies Announces Participation in Upcoming Investor Conferences

Canada NewsWire November 11, 2019

Bausch Health Companies Inc. Announces Third-Quarter 2019 Results and Raises Full-Year Revenue and Adjusted EBITDA (non-GAAP) Guidance Ranges

Canada NewsWire November 4, 2019

Salix Announces Issuance of an Additional XIFAXAN® Patent

Canada NewsWire October 31, 2019

Salix Pharmaceuticals Announces Inaugural Scholarship Program To Commemorate Its 30th Anniversary

Canada NewsWire October 30, 2019

Ahead of World Psoriasis Day, Bausch Health, Canada announces that SILIQ® (brodalumab) is now covered on most drug benefit formularies in Canada

Canada NewsWire October 28, 2019

Salix Pharmaceuticals to Present New Clinical Data at the American College of Gastroenterology (ACG) Annual Meeting

Canada NewsWire October 28, 2019

Bausch Health Licenses Clearside Biomedical's XIPERE(TM) (Triamcinolone Acetonide Suprachoroidal Injectable Suspension), An Investigational Treatment For Macular Edema Associated With Uveitis

PR Newswire October 23, 2019

Bausch + Lomb Introduces PreserVision® AREDS 2 Formula Minigel Eye Vitamins

Canada NewsWire October 21, 2019

Bausch Health Announces Updated Health Canada Safety Information for ELIDEL®

Canada NewsWire October 17, 2019

Bausch Health's Ortho Dermatologics Business To Present Data At The Fall Clinical Dermatology Conference

Canada NewsWire October 15, 2019

Ortho Dermatologics Announces 2019 Aspire Higher Scholarship Recipients

Canada NewsWire October 10, 2019

Bausch + Lomb Announces New Scientific And Clinical Analyses To Be Presented During The American Academy Of Ophthalmology And American Academy Of Optometry Annual Meetings

Canada NewsWire October 7, 2019

Bausch Health Companies Inc. Will Release Third-Quarter 2019 Financial Results on November 4

PR Newswire October 4, 2019

Bausch Health Files Lawsuit Against Sandoz For Infringement Of Patents Protecting XIFAXAN® 550 mg Tablets

Canada NewsWire October 1, 2019

Bausch Health Releases 2018 Corporate Social Responsibility Report

Canada NewsWire September 10, 2019

Bausch Health To Reduce Debt By Approximately $200 Million Using Cash Flow From Operations

Canada NewsWire September 3, 2019

Bausch Health Companies Announces Participation In Upcoming Investor Conferences

Canada NewsWire August 29, 2019

Ortho Dermatologics Announces U.S. FDA Filing Acceptance For IDP-123 Treatment For Acne Vulgaris In Lotion Form

Canada NewsWire August 7, 2019